Sanofi
ENXTPASAN heads into its October earnings window with bears effectively absent from the trade — the interesting tension this week is less about short pressure and more about why the stock keeps sliding despite an almost complete lack of conviction on the short side. Short positioning on Sanofi is about as thin as it gets for a large-cap pharma name. The borrow market has abundant…
SAN cost to borrow surges to 8.06% — up 1,145% in one week from near-zero levels.
Snapshot as of 20 Sept 2026
SAN heads into its October earnings window with bears effectively absent from the trade — the interesting tension this week is less about short pressure and more about why the stock keeps sliding despite an almost…
SAN enters the week carrying two bruises at once — a regulatory headline that spooked investors, and a lending market that flashed its most aggressive signal in months. The catalyst landed on May 6. STAT News reported…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SAN — free to start on ORTEX.
Sign up for free →Open SAN on ORTEX